Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Copeland

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Expert Opinion on Drug Discovery|July 2, 2021
Evolution of the drug-target residence time modelRobert A Copeland
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2013
Molecular pathways: protein methyltransferases in cancerRobert A Copeland
Nature Reviews. Drug Discovery|December 19, 2015
The drug-target residence time model: a 10-year retrospectiveRobert A Copeland
Analytical Biochemistry|August 5, 2003
Mechanistic considerations in high-throughput screeningRobert A Copeland
Nature Chemical Biology|May 26, 2015
Drug-target interactions: Stay tunedRobert A Copeland
Biochemistry|January 9, 2016
The Biochemistry of Chromatin RemodelingRobert A Copeland
ACS Medicinal Chemistry Letters|March 18, 2016
Epigenetic Medicinal ChemistryRobert A Copeland
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discoveryRobert A Copeland
Future Medicinal Chemistry|September 3, 2011
Conformational adaptation in drug-target interactions and residence timeRobert A Copeland
Biochemistry|July 14, 2021
Chance Favors the Perplexed Mind: The Critical Role of Mechanistic Biochemistry in Drug DiscoveryRobert A Copeland
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Discovery|July 2, 2021
Evolution of the drug-target residence time modelRobert A Copeland
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2013
Molecular pathways: protein methyltransferases in cancerRobert A Copeland
Nature Reviews. Drug Discovery|December 19, 2015
The drug-target residence time model: a 10-year retrospectiveRobert A Copeland
Analytical Biochemistry|August 5, 2003
Mechanistic considerations in high-throughput screeningRobert A Copeland
Nature Chemical Biology|May 26, 2015
Drug-target interactions: Stay tunedRobert A Copeland
Biochemistry|January 9, 2016
The Biochemistry of Chromatin RemodelingRobert A Copeland
ACS Medicinal Chemistry Letters|March 18, 2016
Epigenetic Medicinal ChemistryRobert A Copeland
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discoveryRobert A Copeland
Future Medicinal Chemistry|September 3, 2011
Conformational adaptation in drug-target interactions and residence timeRobert A Copeland
Biochemistry|July 14, 2021
Chance Favors the Perplexed Mind: The Critical Role of Mechanistic Biochemistry in Drug DiscoveryRobert A Copeland
Pageof 13